A Retrospective Study on the Use of Chinese Patent Medicine in 24 Medical Institutions for COVID-19 in China

Objective: This research aims to analyze the application regularity of Chinese patent medicine during the COVID-19 epidemic by collecting the names of the top three Chinese patent medicines used by 24 hospitals in 14 provinces of China in four time periods (January 20–22, February 16–18, March 01–03...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Front Pharmacol
Glavni autori: Zhang, Nan, Shi, Nannan, Li, Siyu, Liu, Guoxiu, Han, Yonglong, Liu, Li, Zhang, Xin, Kong, Xiangwen, Zhang, Bihua, Yuan, Wenpeng, Liu, Yi, Deng, Deqiang, Zheng, Minxia, Zhang, Ying, Li, Lihua, Wang, Xiaoping, Wu, Jiankun, Lin, Xiaolan, Nian, Hua, Wu, Xiaohong, Wang, Hua, Liu, Fang, Wang, Hongli, Wang, Hongshun, Liu, Ying, Zeng, Weixin, Yang, Manqin, Wang, Yanping, Zhai, Huaqiang, Wang, Yongyan
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2020
Teme:
Pharmacology
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7990099/
https://ncbi.nlm.nih.gov/pubmed/33776751
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.574562
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items